Standard Biotools Inc. (LAB)
NASDAQ · Healthcare
Standard Biotools Inc. Shareholder Equity 2009–2025
Standard Biotools Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Standard Biotools Inc. shareholder equity as of December 31, 2025: 424.3M, a 10.05% decrease year-over-year.
- Standard Biotools Inc. shareholder equity for 2025 were 424.3M, a 10.05% decrease from 2024.
- Standard Biotools Inc. shareholder equity for 2024 were 471.7M, a 418.62% decrease from 2023.
- Standard Biotools Inc. shareholder equity for 2023 were -148.1M, a 81.73% increase from 2022.
- Standard Biotools Inc. shareholder equity for 2022 were -81.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Standard Biotools Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $424 |
| 2024 | $472 |
| 2023 | $-148 |
| 2022 | $-81 |
| 2021 | $95 |
| 2020 | $139 |
| 2019 | $154 |
| 2018 | $72 |
| 2017 | $31 |
| 2016 | $53 |
| 2015 | $115 |
| 2014 | $150 |
| 2013 | $96 |
| 2012 | $101 |
| 2011 | $57 |
Standard Biotools Inc. Shareholder Equity — FAQ
Standard Biotools Inc. (LAB) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LAB's shareholder equity history?
The chart and table above show Standard Biotools Inc.'s shareholder equity by year and by quarter, including the growth rate.